Prevalence, etiology, and treatment of depression in Parkinson’s disease
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 54 (3) , 363-375
- https://doi.org/10.1016/s0006-3223(03)00530-4
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
- National Institute of Mental Health
This publication has 120 references indexed in Scilit:
- DESIPRAMINE IN TREATMENT OF PARKINSON'S DISEASEActa Neurologica Scandinavica, 2009
- Risk factors for dementia, depression and psychosis in long-standing Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2000
- Maintenance ECT in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1999
- Transient Acute Depression Induced by High-Frequency Deep-Brain StimulationNew England Journal of Medicine, 1999
- Elevated Plasma Levels of Homocysteine inParkinson’s DiseaseEuropean Neurology, 1998
- The motor performance test series in Parkinson's disease is influenced by depressionJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
- Dopamine and depressionJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- In vivo stereological assessment of caudate volume in man: Effect of normal agingLife Sciences, 1990
- Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressantJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1979
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979